[Cause of hospitalization in patients with human immunodeficiency virus infection in a rural area. Role of chronic liver disease]
- PMID: 14987533
- DOI: 10.1016/s0213-005x(04)73053-0
[Cause of hospitalization in patients with human immunodeficiency virus infection in a rural area. Role of chronic liver disease]
Abstract
Objectives: To investigate whether the use of highly active retroviral therapy (HAART) has resulted in changes in the causes of hospitalization in human immunodeficiency virus (HIV)-infected patients and to assess the influence of hepatitis C virus (HCV) infection in this population.
Methods: The causes of hospitalization in HIV-infected patients in our center were retrospectively studied according to two time periods: 1 January 1994 to 31 December 1997 (group 1, no patients treated with HAART) and 1 January 1998 to 30 June 2001 (group 2, 63% of patients treated with HAART). Epidemiological, virological and immunological parameters, and HCV infection data were studied.
Results: As compared to patients in group 1, patients admitted to the hospital in group 2 were older (34.7 +/- 6.3 versus 30.6 +/- 4.6 years, P = 0.0037), had a higher CD4+ lymphocyte count (256 +/- 243 versus 146 (178, P = 0.044) and their hospital stays were significantly lower (7.7 +/- 6.3 versus 17.5 +/- 16.7, P = 0.003). Moreover, the percentage of hospitalizations for AIDS-defining diseases was lower (29% versus 50%, P = 0.046) and the percentage of hospitalizations for decompensated liver disease was higher (22% versus 0%, P = 0.007) in group 2. Among patients who died during hospitalization, there was a higher frequency of low CD4+ lymphocyte counts (77.8% versus 43.3%, P = 0.05), active HCV infection (100% versus 57.9%, P = 0.02) and AIDS-defining disease or decompensated liver disease as the cause of hospitalization (81.8% versus 45%, P = 0.02) than among survivors. Low CD4+ lymphocyte count was independently associated with mortality (OR 1063.1; 95% CI 1.3-838855.5).
Conclusions: Since the introduction of HAART in our setting, the frequency of opportunistic infections has decreased and the frequency of decompensated liver disease has increased among the causes of hospitalization in HIV-infected patients.
Comment in
-
[Hospital admissions and mortality in AIDS patients in the HAART era. Where are we heading?].Enferm Infecc Microbiol Clin. 2004 Mar;22(3):129-32. doi: 10.1157/13058018. Enferm Infecc Microbiol Clin. 2004. PMID: 14987531 Spanish. No abstract available.
-
[Analysis of hospital admittance and mortality in AIDS patients].Enferm Infecc Microbiol Clin. 2004 Aug-Sep;22(7):436; author reply 436-8. doi: 10.1016/s0213-005x(04)73131-6. Enferm Infecc Microbiol Clin. 2004. PMID: 15355778 Spanish. No abstract available.
Similar articles
-
Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.Int J STD AIDS. 2005 Jan;16(1):42-8. doi: 10.1258/0956462052932629. Int J STD AIDS. 2005. PMID: 15705272
-
Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.J Microbiol Immunol Infect. 2016 Aug;49(4):546-53. doi: 10.1016/j.jmii.2014.08.006. Epub 2014 Nov 1. J Microbiol Immunol Infect. 2016. PMID: 25440980
-
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.AIDS. 2006 May 12;20(8):1171-9. doi: 10.1097/01.aids.0000226958.87471.48. AIDS. 2006. PMID: 16691069
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
-
Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.Drug Saf. 2004;27(1):7-24. doi: 10.2165/00002018-200427010-00002. Drug Saf. 2004. PMID: 14720084 Review.
Cited by
-
Hospitalizations and its related factors in HIV/AIDS patients in Tehran, Iran.Med J Islam Repub Iran. 2014 Jul 16;28:70. eCollection 2014. Med J Islam Repub Iran. 2014. PMID: 25405135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials